Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized tranexamic acid for control of hemoptysis
IRCT20170313033051N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in hemoptysis, sponsored by Tehran University of Medical Sciences. Started Apr 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemoptysis
Beyond the preview
Go deeper on IRCT20170313033051N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170313033051N2.